title: Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
abstract: We studied two cases with leukemia that relapsed in the central nervous system (CNS) after allogeneic stem cell transplantation. One patient underwent peripheral blood stem cell transplantation (SCT) from a related, yet haplotype-mismatched, donor for chronic myelomonocytic leukemia. She was kept in complete remission (CR) in the bone marrow (BM) for 7 months, until relapse in the cerebrospinal fluid (CSF) was evident. In the other patient, with acute lymphoblastic leukemia, systemic relapse occurred when he was still on immunosuppression 6 months after SCT from an unrelated donor. After induction chemotherapy following cessation of immunosuppression, the BM examination proved CR. During consolidation chemotherapy, however, he developed leukemic dissemination in the CSF, despite the fact that the BM was in CR. Chimerism status in the BM mononuclear cells and fractionated peripheral blood (PB) cells (granulocytes, T-lymphocytes, and the others) was assessed by short tandem repeat analysis. In both patients, the BM cells and all the fractions of the PB cells proved donor-type chimeras. These results seem to suggest that the graft-versus-leukemia effects might not be as effective in the CNS as in the BM, even when complete T-lymphoid chimerism is achieved.
authors.affiliation: Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan. hohashi@nnh.hosh.go.jp
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Ohashi
authors.forename: Chiaki
authors.initials: C
authors.lastname: Kato
authors.forename: Shoko
authors.initials: S
authors.lastname: Fukami
authors.forename: Hidehiko
authors.initials: H
authors.lastname: Saito
authors.forename: Motohiro
authors.initials: M
authors.lastname: Hamaguchi
mesh_terms: D000328:Adult; D001853:Bone Marrow / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000473:pathology / Q000628:therapy*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000473:pathology / Q000628:therapy; D015477:Leukemia, Myelomonocytic, Chronic / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D036102:Peripheral Blood Stem Cell Transplantation; D012074:Remission Induction; D014019:Tissue Donors; D018183:Transplantation Chimera; D014184:Transplantation, Homologous